Development of co packaging of Viramune® and Combivir® for the developing world

home   >   blogdigger

Boehringer Ingelheim and GlaxoSmithKline plc (GSK) announced today that the companies have signed a letter of intent for an accelerated development programme for a co-package for Viramune® (nevirapine) and Combivir® (lamivudine/zidovudine) for chronic treatment of HIV infection in the developing world... click link for more info.

- link to Development of co packaging of Viramune® and Combivir® for the developing world -
Last update: 05/26/2005

Recommended Reading

    Montelukast approved for seasonal allergies. (New Indication). : An article from: Family Practice News
    Fosamax: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
    Plavix: A Medical Dictionary, Bibliography, And Annotated Research Guide To Internet References
    Primer for Prescription Medications: the antipsychotic medicines--atypical. : An article from: Annals of the American Psychotherapy Association
    Seroquel shortage indicative of supply problems. (Sharp Increase in Drug Shortages). : An article from: Internal Medicine News
    When Painkillers Become Dangerous : What Everyone Needs to Know About OxyContin and Other Prescription Drugs
    New drugs with potential for altering disease. (Diagnosis: MS).(multiple sclerosis) : An article from: Paraplegia News
    Purdue improves e-record tracking of Oxycontin adverse events after audit. (Human Drugs). : An article from: Inspection Monitor